Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Active Pharmaceutical Ingredient Market Portraiture
2.2. Global Active Pharmaceutical Ingredient Market, By API Type, 2017 (US$ Mn)
2.3. Global Active Pharmaceutical Ingredient Market, By Drug Type, 2017 (US$ Mn)
2.4. Global Active Pharmaceutical Ingredient Market, By Manufacturing Type, 2017 (US$ Mn)
2.5. Global Active Pharmaceutical Ingredient Market, by Geography, 2017 Vs 2026 (Value %)
Chapter 3. Global Active Pharmaceutical Ingredient Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Active Pharmaceutical Ingredient Technologies: Future Trends
3.3. Current Scenario: Strategies Used for Shifting Manufacturing Plants Internationally
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2017
3.7. Major Agreements, Partnerships and Collaborations
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2017
Chapter 4. Global Active Pharmaceutical Ingredient Market, by API Type, 2016 – 2026 (US$ Mn)
4.1. Overview
4.2. Synthetic Chemical API
4.3. Biological API
Chapter 5. Global Active Pharmaceutical Ingredient Market, by Drug Type, 2016 – 2026 (US$ Mn)
5.1. Overview
5.2. Branded Drugs
5.3. Generic Drugs
5.4. OTC Drugs
Chapter 6. Global Active Pharmaceutical Ingredient Market, By Manufacturing Type, 2016 – 2026 (US$)
6.1. Overview
6.2. Contract Manufacturers
6.3. Captive Manufacturers
Chapter 7. Global Active Pharmaceutical Ingredient Market, by Geography, 2016 – 2026 (US$ Mn)
7.1. Overview
7.2. North America Active Pharmaceutical Ingredient Market Analysis, 2016 – 2026
7.2.1. North America Active Pharmaceutical Ingredient Market, By API Type, 2016 – 2026 (US$ Mn)
7.2.2. North America Active Pharmaceutical Ingredient Market, By Drug Type, 2016 – 2026 (US$ Mn)
7.2.3. North America Active Pharmaceutical Ingredient Market, By Manufacturing Type, 2016 – 2026 (US$ Mn)
7.2.4. North America Active Pharmaceutical Ingredient Market, by Country, 2016 – 2026 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe Active Pharmaceutical Ingredient Market Analysis, 2016 – 2026
7.3.1. Europe Active Pharmaceutical Ingredient Market, By API Type, 2016 – 2026 (US$ Mn)
7.3.2. Europe Active Pharmaceutical Ingredient Market, By Drug Type, 2016 – 2026 (US$ Mn)
7.3.3. Europe Active Pharmaceutical Ingredient Market, By Manufacturing Type, 2016 – 2026 (US$ Mn)
7.3.4. Europe Active Pharmaceutical Ingredient Market, by Country, 2016 – 2026 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific Active Pharmaceutical Ingredient Market Analysis, 2016 – 2026
7.4.1. Asia Pacific Active Pharmaceutical Ingredient Market, By API Type, 2016 – 2026 (US$ Mn)
7.4.2. Asia Pacific Active Pharmaceutical Ingredient Market, By Drug Type, 2016 – 2026 (US$ Mn)
7.4.3. Asia Pacific Active Pharmaceutical Ingredient Market, By Manufacturing Type, 2016 – 2026 (US$ Mn)
7.4.4. Asia Pacific Active Pharmaceutical Ingredient Market, by Country, 2016 – 2026 (US$ Mn)
7.4.4.1. Japan
7.4.4.2. China
7.4.4.3. Rest of APAC
7.5. Latin America Active Pharmaceutical Ingredient Market Analysis, 2016 – 2026
7.5.1. Latin America Active Pharmaceutical Ingredient Market, By API Type, 2016 – 2026 (US$ Mn)
7.5.2. Latin America Active Pharmaceutical Ingredient Market, By Drug Type, 2016 – 2026 (US$ Mn)
7.5.3. Latin America Active Pharmaceutical Ingredient Market, By Manufacturing Type, 2016 – 2026 (US$ Mn)
7.5.4. Latin America Active Pharmaceutical Ingredient Market, by Country, 2016 – 2026 (US$ Mn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) Active Pharmaceutical Ingredient Market Analysis, 2016 – 2026
7.6.1. MEA Active Pharmaceutical Ingredient Market, by API Type, 2016 – 2026 (US$ Mn)
7.6.2. MEA Active Pharmaceutical Ingredient Market, by Drug Type, 2016 – 2026 (US$ Mn)
7.6.3. MEA Active Pharmaceutical Ingredient Market, By Manufacturing Type, 2016 – 2026 (US$ Mn)
7.6.4. MEA Active Pharmaceutical Ingredient Market, by Region, 2016 – 2026 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA
Chapter 8. Company Profiles
8.1. Teva Pharmaceutical Industries Ltd.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Pfizer, Inc.
8.3. Sanofi
8.4. Boehringer Ingelheim
8.5. Novartis International AG
8.6. Bristol-Myers Squibb
8.7. Eli Lilly and Company
8.8. GlaxoSmithKline plc
8.9. Merck & Co., Inc.
8.10. AbbVie Inc.
8.11. Lonza Group
List of Figures
FIG. 1 Global Active Pharmaceutical Ingredient Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Active Pharmaceutical Ingredient Market Segmentation
FIG. 4 Global Active Pharmaceutical Ingredient Market, by API Type, 2017 (US$ Mn)
FIG. 5 Global Active Pharmaceutical Ingredient Market, by Drug Type, 2017 (US$ Mn)
FIG. 6 Global Active Pharmaceutical Ingredient Market, by Manufacturing Type, 2017 (US$ Mn)
FIG. 7 Global Active Pharmaceutical Ingredient Market, by Geography, 2017 (US$ Mn)
FIG. 8 Attractive Investment Proposition, by Geography, 2017
FIG. 9 Global Market Positioning of Key Active Pharmaceutical Ingredient Manufacturers, 2017
FIG. 10 Global Synthetic Chemical API Type Market, 2016–2026 (US$ Mn)
FIG. 11 Global Biological API Type Market, 2016–2026 (US$ Mn)
FIG. 12 Global Branded Drugs Market, Active Pharmaceutical Ingredient, 2016–2026 (US$ Mn)
FIG. 13 Global Generic Drugs for Active Pharmaceutical Ingredient, 2016–2026 (US$ Mn)
FIG. 14 Global OTC Drugs Market for Active Pharmaceutical Ingredient, 2016–2026 (US$ Mn)
FIG. 15 Global Contract Manufacturers Market for Active Pharmaceutical Ingredient, 2016–2026 (US$ Mn)
FIG. 16 Global Captive Manufacturers Market for Active Pharmaceutical Ingredient, 2016–2026 (US$ Mn)
FIG. 17 U.S. Active Pharmaceutical Ingredient Market, 2016–2026 (US$ Mn)
FIG. 18 Canada Active Pharmaceutical Ingredient Market, 2016–2026 (US$ Mn)
FIG. 19 U.K. Active Pharmaceutical Ingredient Market, 2016–2026 (US$ Mn)
FIG. 20 Germany Active Pharmaceutical Ingredient Market, 2016–2026 (US$ Mn)
FIG. 21 Rest of Europe Active Pharmaceutical Ingredient Market, 2016–2026 (US$ Mn)
FIG. 22 Japan Active Pharmaceutical Ingredient Market, 2016–2026 (US$ Mn)
FIG. 23 China Active Pharmaceutical Ingredient Market, 2016–2026 (US$ Mn)
FIG. 24 Rest of Asia Pacific Active Pharmaceutical Ingredient Market, 2016–2026 (US$ Mn)
FIG. 25 Brazil Active Pharmaceutical Ingredient Market, 2016–2026 (US$ Mn)
FIG. 26 Mexico Active Pharmaceutical Ingredient Market, 2016–2026 (US$ Mn)
FIG. 27 Rest of Latin America Active Pharmaceutical Ingredient Market, 2016–2026 (US$ Mn)
FIG. 28 GCC Active Pharmaceutical Ingredient Market, 2016–2026 (US$ Mn)
FIG. 29 Rest of Middle East & Africa Active Pharmaceutical Ingredient Market, 2016–2026 (US$ Mn)
List of Tables
TABLE 1 Market Snapshot: Global Active Pharmaceutical Ingredient Market
TABLE 2 Global Active Pharmaceutical Ingredient Market, by API Type, 2016–2026 (US$ Mn)
TABLE 3 Global Active Pharmaceutical Ingredient Market, by Drug Type, 2016–2026 (US$ Mn)
TABLE 4 Global Active Pharmaceutical Ingredient Market, by Manufacturing Type, 2016–2026 (US$ Mn)
TABLE 5 Global Active Pharmaceutical Ingredient Market, by Geography, 2016–2026 (US$ Mn)
TABLE 6 North America Active Pharmaceutical Ingredient Market, by API Type, 2016–2026 (US$ Mn)
TABLE 7 North America Active Pharmaceutical Ingredient Market, by Drug Type, 2016–2026 (US$ Mn)
TABLE 8 North America Active Pharmaceutical Ingredient Market, by Manufacturing Type, 2016–2026 (US$ Mn)
TABLE 9 North America Active Pharmaceutical Ingredient Market, by Country, 2016–2026 (US$ Mn)
TABLE 10 Europe Active Pharmaceutical Ingredient Market, by API Type, 2016–2026 (US$ Mn)
TABLE 11 Europe Active Pharmaceutical Ingredient Market, by Drug Type, 2016–2026 (US$ Mn)
TABLE 12 Europe Active Pharmaceutical Ingredient Market, by Manufacturing Type, 2016–2026 (US$ Mn)
TABLE 13 Europe Active Pharmaceutical Ingredient Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 14 Latin America Active Pharmaceutical Ingredient Market, by API Type, 2016–2026 (US$ Mn)
TABLE 15 Latin America Active Pharmaceutical Ingredient Market, by Drug Type, 2016–2026 (US$ Mn)
TABLE 16 Latin America Active Pharmaceutical Ingredient Market, by Manufacturing Type, 2016–2026 (US$ Mn)
TABLE 17 Latin America Active Pharmaceutical Ingredient Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 18 Asia Pacific Active Pharmaceutical Ingredient Market, by API Type, 2016–2026 (US$ Mn)
TABLE 19 Asia Pacific Active Pharmaceutical Ingredient Market, by Drug Type, 2016–2026 (US$ Mn)
TABLE 20 Asia Pacific Active Pharmaceutical Ingredient Market, by Manufacturing Type, 2016–2026 (US$ Mn)
TABLE 21 Asia Pacific Active Pharmaceutical Ingredient Market, by Country/Region, 2016–2026 (US$ Mn)
TABLE 22 Middle East & Africa Active Pharmaceutical Ingredient Market, by API Type, 2016–2026 (US$ Mn)
TABLE 23 Middle East & Africa Active Pharmaceutical Ingredient Market, by Drug Type, 2016–2026 (US$ Mn)
TABLE 24 Middle East & Africa Active Pharmaceutical Ingredient Market, by Manufacturing Type, 2016–2026 (US$ Mn)
TABLE 25 Middle East & Africa Active Pharmaceutical Ingredient Market, by Region, 2016–2026 (US$ Mn)
TABLE 26 Teva Pharmaceutical Industries Ltd.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 27 Pfizer, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 28 Sanofi: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 29 Boehringer Ingelheim: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 30 Novartis International AG.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 31 Bristol-Myers Squibb: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 32 Eli Lilly and Company: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 33 GlaxoSmithKline plc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 34 Merck & Co., Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 35 AbbVie Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 36 Lonza Group: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)